Skip to content

GS PHARMA

Active Private limited companyfounded 2012active for 14 yearsBrusselstraat 5, 1702 DilbeekKBO/BCE: BE 0848.422.277 subsidiary of

Lifetime

13 annual accounts with figures on one time axis
peak of €299,272 in 2025
€299,272▲ 66.2%
lowest -€21,116 in 2021
€124,005▲ 693%
peak of €162,763 in 2018
€148,356unchanged
€648,574▼ 0.7%
peak of 2 FTE in 2025
2 FTE▲ 11.1%
Board1 name since 2012
1 director
Owners
  
Documentsfilings and deeds
20-06-202641 days before the deadline
2025abbreviated format
Gross margin from €180,079 to €299,272Result from €15,644 to €124,005Staff from 1.8 FTE to 2 FTECash from €62,168 to €17,075

Key points

from the 2025 annual accounts

Result

€124,005 ▲ 693%
€15,6002024€124,0002025

The result rose in 2025 from €15,644 to €124,005.

Debts

€648,574 81% of the balance sheet
Financial debts 33%Suppliers 16%Taxes and wages 4%Other 47%

Of this, €557,769 falls due within a year.

Filings

13 annual accounts since 2013
AprilJune31 JulyOctober201520202025

Seven of the last ten came late. The 2024 accounts came in latest, 77 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 5,052 companies had the same profile as GS PHARMA has now. Each dot stands for 13 companies, two years later.

95.9%
were still trading
2.4%
stopped another way
1.6%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency 10 to 30%
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 5,052 companies, not a prediction for GS PHARMA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Manager,
  • 100%equity €1.8m (2024) · annual accounts 31-03-2024 of
Board & ownership

Recent changes

acts as permanent representative holds all the shares · General meeting of 28-04-2023 · Gazette deed
Incorporation Founding capital of €20,000, 1,000 shares · Founded by and · appointed as manager · published on 06-09-2012 · Gazette deed
First establishment Brusselstraat 5, Dilbeek
All 20 events

Comparable companies

same main activity, similar in size and age
Company
GS PHARMA Dilbeek €796,930 €299,272 18.6% 2
Apotheek De Brabanter Jim Pajottegem €765,675 €336,139 42.0% 1.9
PHARMACIE CONSTANT L. La Louvière €739,557 €277,612 61.1% 1.8
Apotheek De Stoop Deinze Deinze €837,549 €347,612 62.5% 2.1
APOTHEEK CAUWENBERGH WOLVERTEM Meise €647,057 €367,104 29.9% 2.1
APOTHEEK JOOSEN Wommelgem €875,867 €322,076 88.0% 2.1
PHARMACIE PACCO Rixensart €716,432 €270,161 45.6% 2

These companies have the same main activity as GS PHARMA: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €647,000 and €876,000, founded between 2010 and 2013.

Official details

Source: KBO
Status
Active since 04-09-2012Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Joint committee
313Pharmacies and pricing offices · annual accounts 2025
Establishment unit
2.212.199.4201702 Dilbeek, since 04-09-2012
Financial year end
31 December
Peppol
Reachable
Company details

Annual accounts 2025

≈ €1.0mestimated
€796,930▼ 0.6%
Employeeson 31-12-2025
2=
Filing
Filed on 20-06-2026, 41 days before the end of the filing period
Financials

Insights on GS PHARMA

GS PHARMA files the abbreviated format. That format states no turnover. The gross margin rose from €172,207 in 2013 to €299,272 in 2025.

holds all the shares.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about GS PHARMA

What is the company number of GS PHARMA?
The company number of GS PHARMA is 0848.422.277. The VAT number is the same number with BE in front: BE 0848.422.277.
Where is GS PHARMA based?
The registered office is at Brusselstraat 5, 1702 Dilbeek.Company details
What does GS PHARMA do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of GS PHARMA?
GS PHARMA is a private limited company (BV).
When was GS PHARMA founded?
GS PHARMA was founded on 04-09-2012.
Is GS PHARMA still active?
Yes, GS PHARMA is an active enterprise in the KBO register.
How many employees does GS PHARMA have?
GS PHARMA had an average of 2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does GS PHARMA fall under?
In its 2025 annual accounts, GS PHARMA states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of GS PHARMA?
The turnover in financial year 2025 is ≈ €1.0m. This figure is estimated from the gross margin of €299,272 and 42 comparable companies (NACE 477). It probably lies between €810,000 and €1.4m.
Is GS PHARMA profitable?
In financial year 2025, GS PHARMA made a profit of €124,005.
Where can I find the annual accounts of GS PHARMA?
GS PHARMA filed 13 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of GS PHARMA due?
GS PHARMA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.